anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

176,221-176,280 of 319,975

filter-aware
36
The slide presents financial performance metrics for Arrival, highlighting the increase in adjusted EBITDA loss year-over-year.Arrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations 1 hit
37
The slide presents financial data for Arrival, showing a significant increase in CAPEX from 2020 to 2021.Arrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations 1 hit
38
The slide is a simple text-based disclosure on a black background.Arrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations 1 hit
39
Arrival | Results Presentation Deck | 42 slidesArrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations Loop · Why Now1 hit
40
The slide uses a combination of icons and a summary table to communicate the financial and operational model of the microfactory concept.Arrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations Loop · Why Now1 hit
41
Arrival | Results Presentation Deck | 42 slidesArrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations 1 hit
42
Arrival | Results Presentation Deck | 42 slidesArrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations 1 hit
01
Slide 1
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
02
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
03
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
04
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
05
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
The slide uses a three-column layout to categorize performance metrics and achievements.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Key Takeaways1 hit
07
The slide presents two side-by-side tables summarizing revenue and growth percentages, with a footnote clarifying the exclusion of Vaxzevria in certain metrics.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Key Takeaways1 hit
08
The slide uses a combination of a product portfolio grid and two pie charts to illustrate business diversification.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Key Takeaways1 hit
09
The slide uses a four-column layout to categorize strategic growth drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Key TakeawaysLoop · Golden Circle1 hit
10
The slide uses a table to categorize pipeline progress by regulatory status and geography.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
11
Includes footnotes explaining CER (constant exchange rates), R&D, SG&A, and pp (percentage points).AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
12
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
13
The slide uses a four-column layout to present financial projections and qualitative business drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
14
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Section DividerLoop · Golden Circle1 hit
15
The waterfall chart includes a specific callout for acquisition-related debt.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
16
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
17
Includes regional breakdown (US, Europe, ERoW, EM) and specific clinical/market drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
18
Includes legend for regional sales and collaboration revenue categories.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
19
The slide uses stacked bar charts to visualize revenue growth by region (US, Europe, ERoW, EM) for two pharmaceutical products.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
20
The slide uses a three-column layout to organize updates by congress, each supported by a specific clinical chart.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
21
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
22
Includes a stacked bar chart for Farxiga revenue and a line chart for Lokelma market share.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
23
Includes product-specific performance charts and bulleted highlights.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
24
The slide uses a combination of big numbers and a table to illustrate the addressable patient population.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
25
The chart shows a stacked bar breakdown of revenue by region (China vs Ex-China) and COVID-19 vaccine sales over 9 quarters.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
26
The slide uses a three-column layout to present product-specific updates.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
27
The slide features a stylized human silhouette with digital/biological imagery, typical of a section transition in a corporate presentation.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
Slide 28 of a presentation, likely from AstraZeneca's financial reporting.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
Uses a patient icon array to illustrate prevalence and a horizontal timeline/spectrum to map MOAs to disease severity.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a Gantt-style chart to visualize drug development phases.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
The slide uses a matrix structure (timeline vs. activity type) to organize upcoming milestones.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
The slide uses a four-pillar icon-based layout to summarize corporate strategy.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
Slide 34 of the deck.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
The chart visualizes emission reduction paths for various companies, while the table ranks them by temperature alignment.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
The slide presents two distinct tables side-by-side for different therapeutic areas.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
The slide uses a stylized silhouette of a human figure with internal molecular/cellular imagery.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide uses a minimalist design with a large number '1' in a circle, suggesting this is the first section or a primary cover.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
The slide uses a matrix-like structure to map patient segments (NHA naive vs experienced) against disease stages (Hormone sensitive vs Castration resistant).AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
Includes ASCO GU 2022 conference branding.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
43
Includes a patient segmentation diagram showing NHA-naïve vs. Prior NHA use populations.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
44
The slide features a stylized silhouette of a human figure with an internal molecular/antibody visualization.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
45
Includes ASCO GI 2022 badge and clinical trial references.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
46
Includes ASCO GI 2022 callout and regulatory submission status.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
47
The slide uses a flow-chart style diagram to map clinical trial targets to specific patient segments.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
48
The slide features a stylized silhouette of a human figure with a molecular/antibody illustration in the chest area.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
49
The slide uses a matrix-like structure to map clinical indications against treatment lines, emphasizing a 'replace/displace' strategy.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
50
The slide uses a matrix-style layout to map clinical trials (DESTINY series) across treatment lines and disease indications.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
51
The slide uses a matrix layout to map drug indications against patient populations and treatment lines.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
52
The slide uses a flow-chart style to segment patient populations.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit
53
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations 1 hit